LGD-6972 is an orally active, selective glucagon receptor (GCGR) antagonist used for research into glucose regulation and type 2 diabetes. It inhibits GCGR signaling to reduce glucagon-stimulated cAMP and hepatic glucose production; reported molecular formula C43H46N2O5S, molecular weight 702.9 g/mol, CAS 1207989-09-0, and typical supplied purity is 98.0%.
- Selective oral GCGR antagonist for glucose regulation research.
- Reduces glucagon-stimulated cAMP and hepatic glucose production.
- Demonstrated glucose-lowering activity in preclinical and clinical studies.
- Available in multiple salt forms and small-scale pack sizes for laboratory use.
- High purity suitable for analytical and biological assays.